Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 24, 2012 - Issue 10
Submit an article Journal homepage
274
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials

Zaynab Essack HIV AIDS Vaccines Ethics Group,School of Psychology, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa
,
Jennifer Koen HIV AIDS Vaccines Ethics Group,School of Psychology, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa
,
Catherine Slack HIV AIDS Vaccines Ethics Group,School of Psychology, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa
,
Graham Lindegger HIV AIDS Vaccines Ethics Group,School of Psychology, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa
&
Peter A. Newman Factor-Inwentash Faculty of Social Work, Centre for Applied Social Research, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
Pages 1249-1254 | Received 11 Mar 2011, Accepted 09 Jan 2012, Published online: 24 Feb 2012

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Clara Rubincam, Peter A. Newman, Millicent Atujuna & Linda-Gail Bekker. (2018) ‘Why would you promote something that is less percent safer than a condom?’: Perspectives on partially effective HIV prevention technologies among key populations in South Africa. SAHARA-J: Journal of Social Aspects of HIV/AIDS 15:1, pages 179-186.
Read now
Peter A Newman & Clara Rubincam. (2014) Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence. Expert Review of Vaccines 13:12, pages 1553-1562.
Read now

Articles from other publishers (8)

Michele P. Andrasik, Fredericka Albertina Sesay, Abby Isaacs, Linda Oseso & Mary Allen. (2020) Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes 84:5, pages 488-496.
Crossref
Peter A. Newman, Catherine M. Slack & Graham Lindegger. (2018) Commentary on “A Framework for Community and Stakeholder Engagement: Experiences From a Multicenter Study in Southern Africa”. Journal of Empirical Research on Human Research Ethics 13:4, pages 333-337.
Crossref
Suzanne Day, Meredith Blumberg, Thi Vu, Yang Zhao, Stuart Rennie & Joseph D. Tucker. (2018) Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence. Journal of the International AIDS Society 21, pages e25174.
Crossref
Arja Halkoaho, Anna-Maija Pietilä, Mette Ebbesen, Suyen Karki & Mari Kangasniemi. (2016) Cultural aspects related to informed consent in health research. Nursing Ethics 23:6, pages 698-712.
Crossref
Peter A. Newman, Clara Rubincam, Catherine Slack, Zaynab Essack, Venkatesan Chakrapani, Deng-Min Chuang, Suchon Tepjan, Murali Shunmugam, Surachet Roungprakhon, Carmen Logie, Jennifer Koen & Graham Lindegger. (2015) Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study. PLOS ONE 10:8, pages e0135937.
Crossref
Sylivia Nalubega & Catrin Evans. (2015) Participant views and experiences of participating in HIV research in sub-Saharan Africa: a qualitative systematic review. JBI Database of Systematic Reviews and Implementation Reports 13:5, pages 330-420.
Crossref
Dan Allman, Melissa Hope Ditmore & Karyn Kaplan. (2014) Improving Ethical and Participatory Practice for Marginalized Populations in Biomedical HIV Prevention Trials: Lessons from Thailand. PLoS ONE 9:6, pages e100058.
Crossref
Jennifer Koen, Zaynab Essack, Catherine Slack, Graham Lindegger & Peter A. Newman. (2013) ‘It Looks Like You Just Want Them When Things Get Rough’: Civil Society Perspectives on Negative Trial Results and Stakeholder Engagement in HIV Prevention Trials. Developing World Bioethics 13:3, pages 138-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.